Paul Yu

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 9

Top Topics

Vascular Endothelial Growth Factor

Diabetic Retinopathy

Top Venues

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Christian T Rutan Woods, Mustafa S Makia, Tylor R Lewis, Ryan Crane, Stephanie Zeibak, Paul Yu, Mashal Kakakhel, Carson M Castillo, Vadim Y Arshavsky, Muna I Naash, Muayyad R Al-Ubaidi
Downregulation of rhodopsin is an effective therapeutic strategy in ameliorating peripherin-2-associated inherited retinal disorders. Nature communications 15 (1) (2024)
Christian T Rutan Woods, Mustafa S Makia, Tylor R Lewis, Ryan Crane, Stephanie Zeibak, Paul Yu, Mashal Kakakhel, Carson M Castillo, Vadim Y Arshavsky, Muna I Naash, Muayyad R Al-Ubaidi
Author Correction: Downregulation of rhodopsin is an effective therapeutic strategy in ameliorating peripherin-2-associated inherited retinal disorders. Nature communications 15 (1) (2024)
Christian T Rutan Woods, Mustafa S Makia, Tylor R Lewis, Ryan Crane, Stephanie Zeibak, Paul Yu, Mashal Kakakhel, Carson M Castillo, Vadim Y Arshavsky, Muna I Naash, Muayyad R Al-Ubaidi
Downregulation of rhodopsin is an effective therapeutic strategy in ameliorating peripherin-2-associated inherited retinal disorders. Nature communications 15 (1) (2024)
Christian T Rutan Woods, Mustafa S Makia, Tylor R Lewis, Ryan Crane, Stephanie Zeibak, Paul Yu, Mashal Kakakhel, Carson M Castillo, Vadim Y Arshavsky, Muna I Naash, Muayyad R Al-Ubaidi
Downregulation of rhodopsin is an effective therapeutic strategy in ameliorating peripherin-2-associated inherited retinal disorders. Nature communications 15 (1) (2024)
Christian T Rutan Woods, Mustafa S Makia, Tylor R Lewis, Ryan Crane, Stephanie Zeibak, Paul Yu, Mashal Kakakhel, Carson M Castillo, Vadim Y Arshavsky, Muna I Naash, Muayyad R Al-Ubaidi
Downregulation of rhodopsin is an effective therapeutic strategy in ameliorating peripherin-2-associated inherited retinal disorders. Nature communications 15 (1) (2024)
Christian T Rutan Woods, Mustafa S Makia, Tylor R Lewis, Ryan Crane, Stephanie Zeibak, Paul Yu, Mashal Kakakhel, Carson M Castillo, Vadim Y Arshavsky, Muna I Naash, Muayyad R Al-Ubaidi
Downregulation of rhodopsin is an effective therapeutic strategy in ameliorating peripherin-2-associated inherited retinal disorders. Nature communications 15 (1) (2024)
Christian T Rutan Woods, Mustafa S Makia, Tylor R Lewis, Ryan Crane, Stephanie Zeibak, Paul Yu, Mashal Kakakhel, Carson M Castillo, Vadim Y Arshavsky, Muna I Naash, Muayyad R Al-Ubaidi
Downregulation of rhodopsin is an effective therapeutic strategy in ameliorating peripherin-2-associated inherited retinal disorders. Nature communications 15 (1) (2024)
Christian T Rutan Woods, Mustafa S Makia, Tylor R Lewis, Ryan Crane, Stephanie Zeibak, Paul Yu, Mashal Kakakhel, Carson M Castillo, Vadim Y Arshavsky, Muna I Naash, Muayyad R Al-Ubaidi
Downregulation of rhodopsin is an effective therapeutic strategy in ameliorating peripherin-2-associated inherited retinal disorders. Nature communications 15 (1) (2024)
Christian T Rutan Woods, Mustafa S Makia, Tylor R Lewis, Ryan Crane, Stephanie Zeibak, Paul Yu, Mashal Kakakhel, Carson M Castillo, Vadim Y Arshavsky, Muna I Naash, Muayyad R Al-Ubaidi
Author Correction: Downregulation of rhodopsin is an effective therapeutic strategy in ameliorating peripherin-2-associated inherited retinal disorders. Nature communications 15 (1) (2024)